Longitudinal validity of spirometers -: a challenge in longitudinal studies

被引:0
|
作者
Künzli, N
Kuna-Dibbert, B
Keidel, D
Keller, R
Brändli, O
Schindler, C
Schweinzer, KM
Leuenberger, P
Ackermann-Liebrich, U
机构
[1] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA
[2] Univ Basel, Inst Social & Prevent Med, Basel, Switzerland
[3] Pulmonol Clin, Aarau, Switzerland
[4] Fed Off, Vienna, Austria
[5] Res Ctr Forests, Vienna, Austria
[6] Univ Lausanne Hosp, Serv Pulmonol, Lausanne, Switzerland
关键词
spirometer comparison; quality control; cohort studies; lung function measurements;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Question understudy: Pulmonary function testing (PFT) in longitudinal studies involves the repeated use of spirometers over long time periods. We assess the comparability of PFT results taken under biologic field conditions using thirteen certified devices of various technology and age. Comparability of measurements across devices and over time is relevant both in clinical and epidemiological research. Methods: Forced Vital Capacity (FVC), Forced Expiratory Volume in the first second (FEV1) and Forced Expiratory Flow 50% (FEF50) were compared before and after the data collection of the Swiss Study on Air Pollution and Lung Diseases in Adults (SAPALDIA) and the European Community Respiratory Health Survey (ECRHS) cohort studies. Three test series were conducted with 46, 50 and 56 volunteers using various combinations of spirometers to compare the eight flow-sensing spirometers (Sensormedics 2200) used in the SAPALDIA cross-sectional and follow-up, two new flow-sensing instruments (Sensormedics V-max) and three volume displacement spirometers (two Biomedin/Baires and one Sensormedics 2400). Results: The initial comparison (1999/2000) of eight Sensormedics 2200 and the follow-up comparison (2003) of the same devices revealed a maximal variation of up to 2.6% for FVC, 2.4% for FEV1 and 2.8% for FEF50 across devices with no indication of systematic differences between spirometers. Results were also reproducible between Biomedin, Sensormedics 2200 and 2400. The new generation of Sensormedics (V-max) gave systematically lower results. Conclusions: The study demonstrates the need to conduct spirometer comparison tests with humans. For follow-up studies we strongly recommend the use of the same spirometers.
引用
收藏
页码:503 / 508
页数:6
相关论文
共 50 条